Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

DiPersio JF et al. – Plerixafor and G–CSF were well tolerated and resulted in a significantly higher proportion of patients with non–Hodgkin's lymphoma achieving the optimal CD34+ cell target for transplantation in fewer apheresis days, compared with G–CSF alone.

Related Articles

Beyond Minimally Important Change: Defining a Successful Outcome of Physical Therapy for Patients With Low Back Pain
Spine, 11/30/09    Relevance Score: 40%

Prehospital paediatric emergency care: paediatric triage
Emergency Medicine Journal, 11/30/09    Relevance Score: 40%

Radiosurgery and whole brain therapy in the treatment of brainstem metastases
Clinical and Translational Oncology, 11/30/09    Relevance Score: 40%

Somatisation in primary care: experiences of primary care physicians involved in a training program and in a randomised controlled trial
BMC Family Practice, 11/30/09    Relevance Score: 40%

Hand-off Education and Evaluation: Piloting the Observed Simulated Hand-off Experience (OSHE)
Journal of General Internal Medicine, 11/24/09    Relevance Score: 40%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address